The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
IMS 2024 | The challenges with treating R/R MM in resource-restricted regions
Hang Quach, MBBS(Hons), SpecCertOC, FRACP, FRCPA, MD, The University of Melbourne, Melbourne, Australia, discusses the challenges in treating relapsed/refractory (R/R) multiple myeloma (MM) in resource-restricted regions, noting that about two-thirds of the world lacks access to comprehensive diagnostic and treatment resources. Prof. Quach emphasizes the impact of delayed presentation, limited access to diagnostics, and restricted therapeutic options, suggesting that accurate diagnosis and improving availability of treatment should be prioritized over complex stratification methods. This interview took place at the 21st International Myeloma Society (IMS) Annual Meeting, held in Rio de Janeiro, Brazil.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
